Regulatory6 Nov 2026, 07:32 pm
Kabra Drugs Ltd: Undertaking for Non-Applicability of Regulation 32
AI Summary
Aanjaay Industries Limited (formerly Kabra Drugs Limited) has submitted an undertaking stating that Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable to the company. This is because the company has not issued any shares through public issue, rights issue, or preferential issue for the quarter ended September 30, 2026. Regulation 32 requires listed entities to report deviations in the use of proceeds from offer documents for such issuances.
Key Highlights
- Company confirms non-applicability of SEBI Regulation 32.
- No public, rights, or preferential issues were made in the relevant quarter.
- Undertaking filed to clarify compliance status.
- Company operates under Aanjaay Industries Limited.
Price Impact
More from KABRADG